The largest database of trusted experimental protocols

Accutase cell detachment solution

Manufactured by Merck Group
Sourced in United States, Germany

Accutase cell detachment solution is a proteolytic enzyme mixture specifically formulated for the gentle dissociation of adherent cells from cell culture surfaces. It is designed to effectively detach cells while minimizing cell damage or disruption of cell surface proteins.

Automatically generated - may contain errors

51 protocols using accutase cell detachment solution

1

Human Follicular Papilla Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human follicular DP cells were purchased from PromoCell (Germany) and cultured in Follicle DP Cell Growth Medium kit (PromoCell) at 37°C in a humidified atmosphere of 5% CO2 in an incubator. The medium was changed every 3 days, and the cells were harvested with Accutase cell detachment solution purchased from Merck Millipore (USA). Additionally, 293T cells were purchased from American Type Culture Collection (USA). Dulbecco’s modified Eagle’s medium (DMEM; Thermo Fisher Scientific, USA) was supplemented with 5% (v/v) fetal bovine serum (FBS) purchased from Sigma-Aldrich, USA. LY294002, a selective phosphatidylinositol 3-kinase (PI3K) inhibitor, and ginsenoside Rg4, derived from black ginseng, were purchased from Merck (Germany) and AREZ Co. Ltd., (Korea), respectively. The T cell-specific transcription factor and lymphoid enhancer-binding factor (TCF/LEF) luciferase reporter plasmids were purchased from Promega (USA). Minoxidil was purchased from Sigma-Aldrich.
+ Open protocol
+ Expand
2

CD133 Expression Analysis in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were harvested and dissociated as previously described16, 17 using Accutase cell detachment solution (Merck Millipore). Dissociated single cells were incubated with rabbit polyclonal anti‐human CD133 (ab19898; Abcam) diluted in FACS buffer (0.5% [w/v] BSA and 0.1% [w/v] sodium azide in PBS) for 30 minutes on ice. Cell suspensions were then washed and incubated with Alexa Fluor 488‐conjugated secondary antibody (Molecular Probes) diluted in FACS buffer for 30 minutes on ice. Cells incubated with secondary antibody only served as negative controls. Cells were sorted using a FACSAria Cell Sorter (Becton Dickinson) and mean fluorescence intensities (MFI) were calculated by subtracting the intensity of the negative controls.
+ Open protocol
+ Expand
3

Antibody Staining and FACS Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
As previously described (Sasaki et al., 2015 (link)), cells were harvested with Accutase® cell detachment solution (Merck Millipore, Billerica, MA, United States), and dissociated single cells were incubated with primary antibodies diluted in fluorescent activated cell sorting (FACS) buffer (0.5% [w/v] bovine serum albumin [BSA] and 0.1% [w/v] sodium azide in PBS) for 30 min on ice. After washing, the cell suspension was incubated with Alexa Fluor® 488-conjugated secondary antibodies (Molecular Probes, Eugene, OR, United States) and diluted in FACS buffer for 30 min on ice. For the detection of GM1 or c-series gangliosides, cells were incubated with Alexa Fluor® 647-conjugated cholera toxin B subunit (Molecular Probes) or APC-conjugated anti-A2B5 antibody (Miltenyi Biotec, Bergisch Gladbach, Germany) diluted in FACS buffer for 30 min on ice, respectively. Cell sorting and analysis were performed using a FACSAria™ Cell Sorter. The following primary antibodies were used: anti-GM3 (NBT Laboratories Inc, Tokyo, Japan), anti-GM2 (TCI, Tokyo, Japan), anti-GD1a (TCI), anti-GT1b (TCI), anti-GD3 (Merck Millipore), anti-GD2 (TCI), and anti-GD1b (TCI). Mean fluorescence intensity was calculated by subtracting the intensity of the control.
+ Open protocol
+ Expand
4

Dexamethasone Modulation of Glioblastoma Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A broad range of dexamethasone concentrations has been used for in vitro studies,17 (link) and the concentration we used (50 µM) falls within this range.18 (link) Single cell suspension of GSCs after 3 minutes exposure to Accutase cell detachment solution (EMD Millipore) were exposed for 6 days to GSC medium containing dexamethasone 50 µM (Sigma) or GSC medium alone as control. Medium was exchanged daily. To validate the in silico prediction in vitro, GSC 3 and 6 were exposed to 0, 25, 50 and 100 µM dexamethasone over three days under stress of concomitant treatment with 500 µM of the alkylating chemotherapeutic agent temozolomide (Sigma, St Louis, MO). Medium was exchanged daily. Total proteins were extracted and analyzed with Western blotting as described above. GSCs exposed to dexamethasone for five days were co-exposed to 10 µM camtothecin19 (link) for 24 hours and cells were harvested for total RNA isolation followed by reverse transcriptase and quantitative PCR.
+ Open protocol
+ Expand
5

Cell Surface ICAM-1 and GM1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
As described in our previous reports [8 (link), 9 (link)], cells were harvested with the Accutase® cell detachment solution (Merck Millipore, Billerica, MA, USA) and dissociated single cells were incubated with FITC-conjugated ICAM-1 (BioLegend, San Diego, CA, USA) or FITC-isotype control (Becton Dickinson, Franklin Lakes, NJ, USA) diluted in FACS buffer (0.5% [w/v] BSA and 0.1% [w/v] sodium azide in PBS) for 30 min on ice. To detect GM1, cells were incubated with Alexa Fluor® 647-conjugated cholera toxin B subunit (Molecular Probes, Eugene, OR, USA) diluted in FACS buffer for 30 min on ice. After washing, cell sorting and analysis were performed using a FACSAria™ Cell Sorter (Becton Dickinson). Mean fluorescence intensities (MFIs) were calculated by subtracting the intensities of the controls.
+ Open protocol
+ Expand
6

Spheroid Dissociation and Lipid Droplet Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For dissociation of spheroids to obtain single spheroid-derived cells, five spheroids were pooled and washed with PBS. One hundred fifty microliter Accutase cell detachment solution (Merck Millipore, #SCR005) was added, followed by careful pipetting. The spheroid solution was incubated for 10 min in Accutase solution followed by another round of pipetting, resulting in a cell suspension.
For LD analysis, the obtained cell suspension was seeded into glass-bottom cellview cell culture dishes (Greiner bio one, #627965) and allowed to re-attach for 4 h. The cells were washed with PBS and incubated in 1:1000 BODIPY 493/503 (Invitrogen, #D3922) in culture medium for 10 min at 37 °C. Cells were washed twice with warm PBS and fixed by incubation with warm 3.7% formaldehyde solution for 10 min at 37 °C. Cells were washed again and mounted in 25 μl Vectashield Antifade Mounting Medium with DAPI (Vector Laboratories, #H-1200-10). LD imaging and volume analysis was performed as described previously (19 (link)). Briefly, images were acquired on a Nikon A1+ confocal laser scanning microscope and analyzed with ImageJ. LD volume was quantified and normalized to cell count. Average LD volume per cell was calculated from three ATGL-KO clones and three control clones from a total of 76 or 80 cells, respectively.
+ Open protocol
+ Expand
7

Robust GBM cell line isolation and culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
To obtain a robust representation of GBM, three independent MD Anderson patient-derived GSC lines (GSC1, GSC3, and GSC6) were isolated and cultured from surgical specimens as described elsewhere.15 (link), 16 (link) In brief, cells were grown in GSC medium consisting of Dulbecco modified Eagle medium (DMEM)/F12 (Corning, Corning, NY) including L-glutamine (Sigma, St Louis, MO), 1× penicillin/streptomycin (Corning), 1× B27 without vitamin A (Life Technologies, Carlsbad, CA), 20 ng/mL basic fibroblast growth factor (VWR, Radnor, PA), and 20 ng/mL epidermal growth factor (EMD Millipore, Billerica, MA) at 37°C in presence of 5% CO2 as defined previously by Singh et al.15 (link) Cells were passaged according to standard protocols with 3 minutes exposure to Accutase cell detachment solution (EMD Millipore) at 37°C.
+ Open protocol
+ Expand
8

Investigating Cannabinoid Receptor Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
CBD was bought from Biomol GmbH (Hamburg, Germany). JWH-133 and THC were bought from Bio-Techne GmbH (Wiesbaden, Germany) and Lipomed GmbH (Herne, Germany), respectively. R(+)-methanandamide, capsazepine and NAC were obtained from Sigma-Aldrich (Taufkirchen, Germany). AM251 and AM630 were obtained from Biozol (Eching, Germany). O-1602 and O-1918 were purchased from Tocris Bioscience (Bristol, UK) and Cayman Chemicals (Ann Arbor, Michigan, USA), respectively. SnPPIX was obtained from Enzo Life Sciences (Lörrach, Germany). The transfection reagent Lipofectamine™ RNAiMAX, OptiMEM and hPDGF-BB were purchased from Thermo Fisher Scientific Inc. (Schwerte, Germany). siRNA targeting HO-1 was purchased from Santa Cruz Biotechnology (Heidelberg, Germany; sc-35554). Negative control siRNA was from Qiagen (Hilden, Germany; cat. no. 1022076). Accutase cell detachment solution was obtained from Merck Chemicals GmbH (Darmstadt, Germany).
+ Open protocol
+ Expand
9

Cytogenetic Analysis of GRX Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
GRX cells were detached from the petri dish by Accutase cell detachment solution (Merck, Sigma-Aldrich, Taufkirchen, Germany) and transferred in T25 flasks and cultured for two days. The cultures were harvested following standard protocols including treatment with colcemid (10 µg/mL), hypotonic KCl solution (0.4%), and fixative (methanol: acetic acid (3:1)). G-banding by pancreatin staining with Giemsa (GPG) was performed following standard procedures. Cytogenetic analysis was done using an Axioplan 2 imaging microscope (Carl Zeiss, Oberkochen, Germany). For conventional chromosome analysis, five cells were analyzed by light microscopy. Karyotyping was done by using the IKAROS karyotyping system, version 5.9.1 (MetaSystems, Altlussheim, Germany). With this method, an average banding resolution of 250 bands was achieved. Aberrations were described according to the guidelines proposed by the International Committee on Standardized Genetic Nomenclature for Mice that were revised in September 2021 [22 ].
+ Open protocol
+ Expand
10

Immunophenotyping of Cell Surface Antigens

Check if the same lab product or an alternative is used in the 5 most similar protocols
In general, trypsinization reduces the abundance of some cell surface antigens. Therefore, to avoid this effect, cells were harvested with Accutase® cell detachment solution (Merck Millipore, Billerica, MA), and these dissociated single cells were incubated with primary antibodies diluted in FACS buffer (0.5% (w/w) BSA and 0.1% (w/w) sodium azide in PBS) for 30 min on ice. After washing, the cell suspension was incubated with Alexa Fluor® 488- or Alexa Fluor® 647-conjugated secondary antibodies (Molecular Probes, Eugene, OR) diluted in FACS buffer for 30 min on ice. For the detection of GM1, cells were incubated with Alexa Fluor® 647-conjugated cholera toxin B subunit (Molecular Probes) diluted in FACS buffer (0.5% BSA and 0.1% sodium azide in PBS) for 30 min on ice. Cell sorting and analysis were performed using a FACSAriaTM Cell Sorter (BD Biosciences). We used the following primary antibodies: anti-GM3 (NBT Laboratories Inc., Tokyo, Japan); anti-monosialotrihexosylceramide (GM2) (TCI, Tokyo, Japan); anti-monosialotrihexosylceramide (GD1a) (TCI); anti-ganglioside GD3 (Merck Millipore); anti-ganglioside GD2 (TCI); anti-ganglioside GD1b (TCI); and anti-insulin receptor (IR)α (Abcam, Cambridge, UK).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!